AltaCorp Capital reaffirmed their outperform rating on shares of Hexo (TSE:HEXO) in a report released on Thursday morning, BayStreet.CA reports. AltaCorp Capital currently has a C$10.50 target price on the stock.
HEXO has been the subject of a number of other research reports. Canaccord Genuity boosted their target price on shares of Hexo from C$7.50 to C$10.00 in a research report on Friday, March 15th. CIBC raised their price target on shares of Hexo from C$8.50 to C$9.50 in a research report on Friday, March 15th. BMO Capital Markets lifted their price objective on shares of Hexo from C$6.00 to C$9.00 in a research note on Friday, March 15th. Oppenheimer began coverage on shares of Hexo in a research note on Tuesday, February 19th. They issued an outperform rating and a C$7.00 price objective for the company. Finally, Jefferies Financial Group reissued an underperform rating and issued a C$5.60 price objective on shares of Hexo in a report on Monday, February 25th.
HEXO opened at C$8.85 on Thursday. Hexo has a fifty-two week low of C$3.34 and a fifty-two week high of C$9.70. The firm has a market cap of $1.83 billion and a PE ratio of -56.73.
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Recommended Story: What is the yield curve?
Receive News & Ratings for Hexo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexo and related companies with MarketBeat.com's FREE daily email newsletter.